Cargando…

The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer and also one of the most poorly understood. Other health issues that are affecting women with increasing frequency are obesity and diabetes, which are associated with dysglycemia and increased blood glucose. The Warburg Effect des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kellenberger, L. D., Bruin, J. E., Greenaway, J., Campbell, N. E., Moorehead, R. A., Holloway, A. C., Petrik, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825545/ https://www.ncbi.nlm.nih.gov/pubmed/20182531 http://dx.doi.org/10.1155/2010/514310

Ejemplares similares

Extracellular Matrix Proteins and Tumor Angiogenesis
por: Campbell, N. E., et al.
Publicado: (2010)

Akt isoform specific effects in ovarian cancer progression
por: Linnerth-Petrik, Nicolle M., et al.
Publicado: (2016)

Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer
por: Greenaway, James B., et al.
Publicado: (2016)

ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis
por: Campbell, Craig I, et al.
Publicado: (2010)

The effects of polycyclic aromatic compounds (PACs) on mammalian ovarian function
por: Perono, Genevieve A, et al.
Publicado: (2022)

Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancer
por: Manders, Dustin B., et al.
Publicado: (2018)

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease()
por: Dunn, Laura, et al.
Publicado: (2014)

Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2023)

Dysregulated Estrogen Receptor Signaling in the Hypothalamic-Pituitary-Ovarian Axis Leads to Ovarian Epithelial Tumorigenesis in Mice
por: Laws, Mary J., et al.
Publicado: (2014)

Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
por: Marbaniang, Casterland, et al.
Publicado: (2018)

Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
por: Pereira, Madison, et al.
Publicado: (2021)

Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells
por: Pastò, Anna, et al.
Publicado: (2016)

Dysregulation of glucose metabolism in enterally fed patients with acute pancreatitis
por: Tesinsky, P, et al.
Publicado: (1999)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Effects of dysregulated glucose metabolism on the occurrence and ART outcome of endometriosis
por: Chen, Jian-Peng, et al.
Publicado: (2023)

Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice
por: Pang, Jingbo, et al.
Publicado: (2013)

Role of tumour markers in monitoring epithelial ovarian cancer
por: Meyer, T, et al.
Publicado: (2000)

Dysregulation of Cholesterol Homeostasis in Ovarian Cancer
por: Qusairy, Zahraa, et al.
Publicado: (2023)

Tumor metabolism rewiring in epithelial ovarian cancer
por: Wang, Ming, et al.
Publicado: (2023)

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
por: Grajales, Diana, et al.
Publicado: (2019)

Screening for colorectal cancer.
por: Campbell, W. J., et al.
Publicado: (1997)

Role of lymphangiogenesis in epithelial ovarian cancer
por: Sundar, S S, et al.
Publicado: (2006)

The Role of TWIST in Ovarian Epithelial Cancers
por: Kim, Kyungbin, et al.
Publicado: (2014)

Sarcopenia Is a Cause and Consequence of Metabolic Dysregulation in Aging Humans: Effects of Gut Dysbiosis, Glucose Dysregulation, Diet and Lifestyle
por: Daily, James W., et al.
Publicado: (2022)

The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
por: Gien, Lilian T., et al.
Publicado: (2010)

Dysregulation of Dicer1 in Beta Cells Impairs Islet Architecture and Glucose Metabolism
por: Mandelbaum, Amitai D., et al.
Publicado: (2012)

Dysregulated Glucose Metabolism as a Therapeutic Target to Reduce Post-traumatic Epilepsy
por: Koenig, Jenny B., et al.
Publicado: (2018)

Airway epithelial regeneration requires autophagy and glucose metabolism
por: Li, Kuan, et al.
Publicado: (2019)

Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells
por: Urzúa, Ulises, et al.
Publicado: (2016)

The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis—Dysregulation by the Liver
por: London, Amalie, et al.
Publicado: (2021)

The role of intestine in metabolic dysregulation in murine Wilson disease
por: Sarode, Gaurav V., et al.
Publicado: (2023)

The role of surgery in advanced epithelial ovarian cancer
por: Martín-Cameán, María, et al.
Publicado: (2016)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

PARPi after PARPi in epithelial ovarian cancer
por: Essel, K.G., et al.
Publicado: (2021)

Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity
por: Cheng, Lili, et al.
Publicado: (2017)

Dysregulated mitochondrial metabolism upon cigarette smoke exposure in various human bronchial epithelial cell models
por: Tulen, Christy B. M., et al.
Publicado: (2022)

Mice Deficient in Sfrp1 Exhibit Increased Adiposity, Dysregulated Glucose Metabolism, and Enhanced Macrophage Infiltration
por: Gauger, Kelly J., et al.
Publicado: (2013)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

Platinum-Taxol non-cross resistance in epithelial ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1995)

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
por: Hasan, J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_msa997ritl32cgopj7sn271jv6